- Research works
- 28 ▲ 124% vs 2013–17
- Citations
- 314 11.1 per fractional work
- Top-10% rate
- 16.1% record average 16.5%
- Open access
- 54% world 28%
Not ranked overall: Biodesigns (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.6×. Every wedge is a field page.
Which keywords describe research at Biodesigns (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Targeted Therapy, Cancer Genomics, Mutational Signatures, Bioinformatics, Gene Expression, DNA Computing, Molecular Computation and Reproducibility.
- Lubricants
- Ionic Liquids
- Molecular Dynamics
- Scientific Workflows
- Molecular Computation
- Nanoparticles
- Bioinformatics
- Cancer Genomics
- Targeted Therapy
- Mutational Signatures
- Gene Expression
- DNA Computing
- Reproducibility
- Clinical Trials
- Biomarkers
- Graphene
- Tribology
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 17 words, with their numbers
- Targeted Therapy3▲ 56×3 topics
- Cancer Genomics2▲ 159×1 topic
- Mutational Signatures2▲ 159×1 topic
- Bioinformatics2▲ 52×3 topics
- Gene Expression2▲ 8.8×6 topics
- Nanoparticles2▲ 4.0×7 topics
- DNA Computing1▲ 310×1 topic
- Molecular Computation1▲ 310×1 topic
- Reproducibility1▲ 143×1 topic
- Scientific Workflows1▲ 143×1 topic
- Clinical Trials1▲ 6.9×4 topics
- Molecular Dynamics1▲ 17×3 topics
- Biomarkers1▲ 6.5×5 topics
- Ionic Liquids1▲ 12×3 topics
- Graphene1▲ 7.2×2 topics
- Lubricants1▲ 167×1 topic
- Tribology1▲ 93×1 topic
Which research topics does Biodesigns (United States) publish most on?
By volume in 2022–2025: Cancer Genomics and Diagnostics, Lubricants and Their Additives, CRISPR and Genetic Engineering and Genetics, Bioinformatics, and Biomedical Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Genomics and Diagnostics Cancer Research 1 works
- 2 Lubricants and Their Additives Mechanical Engineering 1 works
- 3 CRISPR and Genetic Engineering Molecular Biology 0 works
- 4 Genetics, Bioinformatics, and Biomedical Research Molecular Biology 0 works
- 5 RNA and protein synthesis mechanisms Molecular Biology 0 works
- 6 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
- 7 Intensive Care Unit Cognitive Disorders Critical Care and Intensive Care Medicine 0 works
- 8 Biomedical and Engineering Education Biomedical Engineering 0 works
- 9 Ion channel regulation and function Molecular Biology 0 works
- 10 Design Education and Practice Mechanical Engineering 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Biodesigns (United States)'s research output changed?
Output in 2018–2022 was 124% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Westlake Village
- Heart Foundation
- Instrumental Polymer Technologies (United States)
- MATECH (United States)
- CreoNex Systems (United States)
- HyPerComp (United States)
- Magzor (United States)
- Nutritional Oncology Research Institute
- Biostruxs (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.